table of content
1 Introduction to Research & Analysis Reports
1.1 Metastatic Melanoma Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metastatic Melanoma Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metastatic Melanoma Diagnostic Overall Market Size
2.1 Global Metastatic Melanoma Diagnostic Market Size: 2022 VS 2030
2.2 Global Metastatic Melanoma Diagnostic Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metastatic Melanoma Diagnostic Players in Global Market
3.2 Top Global Metastatic Melanoma Diagnostic Companies Ranked by Revenue
3.3 Global Metastatic Melanoma Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Metastatic Melanoma Diagnostic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Metastatic Melanoma Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metastatic Melanoma Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Metastatic Melanoma Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Metastatic Melanoma Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Metastatic Melanoma Diagnostic Market Size Markets, 2022 & 2030
4.1.2 BRAF Mutation
4.1.3 Circulating Tumor Cells (CTCs)
4.1.4 Immunohistochemistry
4.1.5 Others
4.2 By Type - Global Metastatic Melanoma Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Metastatic Melanoma Diagnostic Revenue, 2018-2023
4.2.2 By Type - Global Metastatic Melanoma Diagnostic Revenue, 2024-2030
4.2.3 By Type - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metastatic Melanoma Diagnostic Market Size, 2022 & 2030
5.1.2 Pathology Laboratories
5.1.3 Hospitals
5.1.4 Cancer Research Centres
5.1.5 Others
5.2 By Application - Global Metastatic Melanoma Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Metastatic Melanoma Diagnostic Revenue, 2018-2023
5.2.2 By Application - Global Metastatic Melanoma Diagnostic Revenue, 2024-2030
5.2.3 By Application - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Metastatic Melanoma Diagnostic Market Size, 2022 & 2030
6.2 By Region - Global Metastatic Melanoma Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Metastatic Melanoma Diagnostic Revenue, 2018-2023
6.2.2 By Region - Global Metastatic Melanoma Diagnostic Revenue, 2024-2030
6.2.3 By Region - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Metastatic Melanoma Diagnostic Revenue, 2018-2030
6.3.2 US Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.3.3 Canada Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.3.4 Mexico Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Metastatic Melanoma Diagnostic Revenue, 2018-2030
6.4.2 Germany Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.3 France Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.4 U.K. Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.5 Italy Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.6 Russia Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.7 Nordic Countries Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.8 Benelux Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Metastatic Melanoma Diagnostic Revenue, 2018-2030
6.5.2 China Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.5.3 Japan Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.5.4 South Korea Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.5.5 Southeast Asia Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.5.6 India Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Metastatic Melanoma Diagnostic Revenue, 2018-2030
6.6.2 Brazil Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.6.3 Argentina Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metastatic Melanoma Diagnostic Revenue, 2018-2030
6.7.2 Turkey Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.7.3 Israel Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.7.4 Saudi Arabia Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.7.5 UAE Metastatic Melanoma Diagnostic Market Size, 2018-2030
7 Metastatic Melanoma Diagnostic Companies Profiles
7.1 Myriad Genetics
7.1.1 Myriad Genetics Company Summary
7.1.2 Myriad Genetics Business Overview
7.1.3 Myriad Genetics Metastatic Melanoma Diagnostic Major Product Offerings
7.1.4 Myriad Genetics Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.1.5 Myriad Genetics Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Metastatic Melanoma Diagnostic Major Product Offerings
7.2.4 Abbott Laboratories Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Foundation Medicine
7.3.1 Foundation Medicine Company Summary
7.3.2 Foundation Medicine Business Overview
7.3.3 Foundation Medicine Metastatic Melanoma Diagnostic Major Product Offerings
7.3.4 Foundation Medicine Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.3.5 Foundation Medicine Key News & Latest Developments
7.4 Pathway Genomics Corporation
7.4.1 Pathway Genomics Corporation Company Summary
7.4.2 Pathway Genomics Corporation Business Overview
7.4.3 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Major Product Offerings
7.4.4 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.4.5 Pathway Genomics Corporation Key News & Latest Developments
7.5 Cancer Genetics
7.5.1 Cancer Genetics Company Summary
7.5.2 Cancer Genetics Business Overview
7.5.3 Cancer Genetics Metastatic Melanoma Diagnostic Major Product Offerings
7.5.4 Cancer Genetics Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.5.5 Cancer Genetics Key News & Latest Developments
7.6 Castle Biosciences
7.6.1 Castle Biosciences Company Summary
7.6.2 Castle Biosciences Business Overview
7.6.3 Castle Biosciences Metastatic Melanoma Diagnostic Major Product Offerings
7.6.4 Castle Biosciences Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.6.5 Castle Biosciences Key News & Latest Developments
7.7 NeoGenomics
7.7.1 NeoGenomics Company Summary
7.7.2 NeoGenomics Business Overview
7.7.3 NeoGenomics Metastatic Melanoma Diagnostic Major Product Offerings
7.7.4 NeoGenomics Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.7.5 NeoGenomics Key News & Latest Developments
7.8 Dermtech
7.8.1 Dermtech Company Summary
7.8.2 Dermtech Business Overview
7.8.3 Dermtech Metastatic Melanoma Diagnostic Major Product Offerings
7.8.4 Dermtech Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.8.5 Dermtech Key News & Latest Developments
7.9 Sysmex Inostics
7.9.1 Sysmex Inostics Company Summary
7.9.2 Sysmex Inostics Business Overview
7.9.3 Sysmex Inostics Metastatic Melanoma Diagnostic Major Product Offerings
7.9.4 Sysmex Inostics Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.9.5 Sysmex Inostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
